PRESCRIBING · PART D · 2024
Total Rx claims
576
Beneficiaries
—
Total drug cost
$2.3M
Distinct drugs
18
Brand share
34.2%
Top prescribed drugs
Rifaximin96 claims
Tacrolimus88 claims
Ursodiol59 claims
Tenofovir Alafenamide37 claims
Pantoprazole Sodium35 claims
QUALITY · MIPS · 2024
Final MIPS score
80.9
Quality
61.9
Cost
74.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.25%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$19K
Payment records
1
By payment type
Consulting Fee$19K
Top paying entities
Consulting Fee$19K
CROSS-REFERENCE